{
    "code": 0,
    "data": [
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 05th February 2026.",
            "news_id": "7bc0b385-e18a-4657-9587-88362212657b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eca3970-89d2-42e5-ba67-8ab7bc7e1dc9.pdf",
            "news_date": "2026-02-11 19:11:07",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 5th February 2026",
            "news_id": "505595c3-20e7-4af7-90b3-23ac55ed5934",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cc9e401-65c8-4f78-9667-24920ae9e549.pdf",
            "news_date": "2026-02-05 19:26:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Revised Investor Presentation",
            "news_id": "93c714a5-4b15-4514-ad80-341b85e452fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46c93f24-1700-455c-b9cd-ab997c99dfbc.pdf",
            "news_date": "2026-02-05 15:12:52",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Unaudited financial results for the quarter and nine months ended 31st  December 2025",
            "news_id": "a258be3d-cbdc-4091-ba75-49d084c00301",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e184f18-4280-4bd6-9651-fc572826dbde.pdf",
            "news_date": "2026-02-05 14:22:47",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation",
            "news_id": "ab43ca2d-7ec4-42b1-b6a7-5197060cb126",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92917fa-fbdb-465c-bab7-1d2b1baaccf1.pdf",
            "news_date": "2026-02-05 14:16:29",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 04th November 2025",
            "news_id": "61f14f21-bc45-4a50-94c3-868bef22417e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6924be80-9862-464e-a101-818e32429b4a.pdf",
            "news_date": "2025-11-11 12:07:29",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 4th November 2025",
            "news_id": "b75563df-9484-48d0-9861-6d2d491c6284",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa23abbc-df33-4317-ade0-afa39e00919b.pdf",
            "news_date": "2025-11-04 18:01:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025",
            "news_id": "b33111a0-2678-460f-b1df-d9d6670520ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7517e5c0-3e56-45fc-acd9-d392c6e0f2a9.pdf",
            "news_date": "2025-11-04 14:47:49",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. ",
            "news_body": "Please find attached unaudited financial results for the quarter and half year ended 30th September 2025",
            "news_id": "607f1158-66ed-42e8-b220-bd09b35d3a32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b69ed5-405a-4863-8aa0-4e2b2b983e92.pdf",
            "news_date": "2025-11-04 14:39:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 5th August 2025",
            "news_id": "97df9a45-8450-4f64-915a-4c2c900342a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aba494e6-578f-473d-9265-6714f15dcd32.pdf",
            "news_date": "2025-08-11 19:36:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 5th August 2025",
            "news_id": "282faefb-805d-46ee-8335-8bd5ce6a8e23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fbf5cc2-c97c-4231-ae49-d56e6960a0cd.pdf",
            "news_date": "2025-08-05 20:45:42",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Qtr Ended 30Th June 2025.",
            "news_body": "Please find the unaudited financial Results for the quarter ended results 30th June 2025.",
            "news_id": "058f6600-24fa-47b5-a20b-b0f81f11b07c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cefcecec-aceb-453e-85f8-e1b83fd2b5de.pdf",
            "news_date": "2025-08-05 13:21:11",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation",
            "news_id": "c7f50ef2-19ed-4d2b-8211-a43615ee8bc9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83d227fb-47b0-46f6-8347-601c06bb1b4c.pdf",
            "news_date": "2025-08-05 13:11:10",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached the transcript of the post results conference call.",
            "news_id": "b8b2d1c2-0e49-485f-9ae0-c02febab85ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0aef0e86-5752-47d8-92db-937dfd500357.pdf",
            "news_date": "2025-05-12 19:11:44",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 6th May 2025",
            "news_id": "696017a4-cd9d-4f5c-97de-d7312af0a13d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80ac3eb5-e214-4a21-919f-33239b2a419c.pdf",
            "news_date": "2025-05-06 19:12:12",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Financial Year Ended 31St March 2025",
            "news_body": "Please find attached herewith the Financial Results for the quarter and Financial Year ended 31st March 2025",
            "news_id": "8bbc459f-10fa-44c7-8690-0cf7bf3953ef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da588a9e-d79f-4c45-aca0-a50e01bd1602.pdf",
            "news_date": "2025-05-06 14:10:20",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Investor Presentation.",
            "news_id": "5dde75af-10d8-4a57-97b6-487d669c5b0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc5456a4-8aaa-4a0b-b1b4-79046750b3f1.pdf",
            "news_date": "2025-05-06 14:00:03",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Please Find Attached Herewith The Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "c193e1f2-c25b-4155-990b-b92a3425d528",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=570a7297-1b32-45b9-83fe-1405171a664f.pdf",
            "news_date": "2025-05-06 13:53:33",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the Investor Presentation.",
            "news_id": "9b689706-6182-4cc6-8ac7-d2126f00cb93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=404caac6-1986-45e2-a318-fb6c9d5e9db2.pdf",
            "news_date": "2025-02-03 14:42:48",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Results for the quarter and nine months ended 31st December 2024",
            "news_id": "7336af47-9cd6-4084-b516-aee8a900d8a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8bea75b-3c20-44cf-87d8-ca9409741f82.pdf",
            "news_date": "2025-02-03 14:37:30",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on 7th November, 2024",
            "news_id": "29261bd8-31b2-4c3b-a732-fc63dd58b94c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a0765f9-861d-4c5a-8f07-9523c029f51f.pdf",
            "news_date": "2024-11-12 15:31:18",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith the Audio Recording of Post Results Conference Call held on 7th November, 2024",
            "news_id": "cee4ed13-3930-4f92-8b62-ac80e0f4dda7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56cbabbf-4b4b-4d37-82fc-29b6e36ed6c8.pdf",
            "news_date": "2024-11-07 18:26:45",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Investor Presentation on the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024.",
            "news_id": "314dab5a-de73-4673-a953-0fcee38ca1bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22572b54-188f-44bd-a37e-45868dabc316.pdf",
            "news_date": "2024-11-07 13:19:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year  Ended September, 2024",
            "news_body": "The exchange is hereby informed  that the Board of Directors at their meeting held today has approved the Unaudited Financial Results for the quarter and half year ended September, 2024",
            "news_id": "3cf806a2-7d8d-4d57-8ffa-9e22bdeb7360",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b085f3ba-bd00-4c4d-a466-d4d16009f3bd.pdf",
            "news_date": "2024-11-07 13:06:20",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement Under Regulation 30 (LODR) - Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on 8th August, 2024",
            "news_id": "31f097c6-c003-4be5-8813-007e2378ca41",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c798dfcf-c04a-4179-955f-b1dba967f348.pdf",
            "news_date": "2024-08-14 15:42:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith the Audio Recording of Post Results Conference Call held on 8th August, 2024",
            "news_id": "ecb0a65a-a5a1-4764-9ea2-ca96ce46ef37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8efdf2-fa79-4e0e-9c79-89fe3829a68c.pdf",
            "news_date": "2024-08-08 19:27:42",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the Investor Presentation on the Unaudited Financial Results of the Company for the quarter ended June 30, 2024. Kindly take the same in record.",
            "news_id": "93bde81a-33c0-4db3-aadd-3f38539227c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5a6ce8c-3ba7-4ab7-b19c-da1c0175ccd2.pdf",
            "news_date": "2024-08-08 13:45:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June, 2024",
            "news_body": "The exchange is hereby informed that the Board of Directors in their Meeting held today has approved the Unaudited Financial Results for the Quarter ended June, 2024.",
            "news_id": "918db1c0-72aa-4fa0-a1ef-2e4247038fc6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51ba19f8-9eb7-45a0-a522-22edb3342b7c.pdf",
            "news_date": "2024-08-08 13:35:37",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcripts of the Earnings Call held on 9th May, 2024.",
            "news_id": "d37690a3-4df8-4a70-a7f2-f11c1171df0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38f03d7c-fbef-489e-9535-0b88440b447e.pdf",
            "news_date": "2024-05-15 19:03:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached the Audio Recording of the Post Results Conference call.",
            "news_id": "22c9df89-cb73-41f9-8141-35eb338706ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87cd1c1a-e839-484a-b02d-2c4f6e5c95a6.pdf",
            "news_date": "2024-05-09 21:43:43",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the Investor Presentation of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024. We request you to kindly take the same in record.",
            "news_id": "43753ad7-3532-4f15-aaa7-faec20561c04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2757b7cf-72f7-4d5f-9279-74cd78a61d8b.pdf",
            "news_date": "2024-05-09 14:23:03",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "The exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its Meeting held today inter alia approved the Audited Financial results for the Quarter and Financial year ended March 31, 2024 and recommended dividend of Rs. 11/- (550%) per Equity Share.",
            "news_id": "529f2064-e79c-42dc-91c3-f68b91400ea9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2b89164-67a3-46c3-9fc5-cda72189d4c3.pdf",
            "news_date": "2024-05-09 14:17:15",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on 5th February, 2024",
            "news_id": "d791aa55-dd8e-4ce5-96aa-5793ea8db2e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17b6d93c-a135-4678-a5f9-8c6003e45819.pdf",
            "news_date": "2024-02-09 17:56:12",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned subject, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/",
            "news_id": "960ed5e7-ebbe-4cea-8b9e-16383c7de564",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52531677-8b20-47ec-aca6-d7e241a66dc9.pdf",
            "news_date": "2024-02-05 19:59:14",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Investor Presentation",
            "news_id": "57e1d5ca-e4b3-422d-af8e-2e8bc388d7bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d7b4bc1-ec33-4a51-b73e-0fee5ef0326e.pdf",
            "news_date": "2024-02-05 14:23:10",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 31St December, 2023",
            "news_body": "Please find attached herewith the Unaudited Financial results for the quarter and half year ended 31st December, 2023",
            "news_id": "0cce015e-762b-4ece-a1e7-6827b23f6595",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a8b90e0-22b2-42b8-ae90-35ed8bd8de96.pdf",
            "news_date": "2024-02-05 14:17:14",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached schedule of Post Results Conference Call",
            "news_id": "ef8c36d9-00f7-4f9f-9bb7-6b59d677c496",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5e6a1ae-0c71-4313-9dc5-4575a372e619.pdf",
            "news_date": "2024-01-18 19:31:11",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached the audio recording.",
            "news_id": "e87dd306-ed11-40b3-a303-dee190600900",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63c3856b-64a9-4196-9e99-ce802dfaded1.pdf",
            "news_date": "2023-11-07 19:13:44",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "PLease find attached the investor presentation",
            "news_id": "6a3e27ac-a112-4c7d-9ec6-40eb329dfdeb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c84ed0d-b30b-459a-bc50-fad68e99cfb5.pdf",
            "news_date": "2023-11-07 13:47:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results 30Th September, 2023",
            "news_body": "PLease find attached the Results",
            "news_id": "f54635f5-b76e-4958-b075-ce6c1b329608",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9e50549-3f73-4de6-b5b6-a3f98b03eae0.pdf",
            "news_date": "2023-11-07 13:43:04",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the Transcript of the Conference call held on 4th August, 2023.",
            "news_id": "2c6da3c8-e1f8-4ba5-a716-8ec2a6e520a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6c94a76-02f2-405b-ad92-85becb5a6404.pdf",
            "news_date": "2023-08-09 18:55:46",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned subject, this is to inform the exchange that the audio recording has been hosted on the website of the Company",
            "news_id": "19007a01-d24f-481c-b5fa-4a23cb5a915e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b9a2e4b-4ca0-4a0f-b213-a9604a22bb25.pdf",
            "news_date": "2023-08-04 20:44:16",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the Investor Presentation for the quarter ended 30th June, 2023",
            "news_id": "251fd446-22c9-4a43-ada1-3326f35b0e19",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1b264b5-0c02-478f-9be4-bdb2fa40e3e3.pdf",
            "news_date": "2023-08-04 13:41:49",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2023",
            "news_body": "Please find enclosed the Unaudited Financial Results for the qtr ended 30th June, 2023",
            "news_id": "96efb62d-6300-4910-8ea6-9a63711d83f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6684c470-f7ba-48d1-a426-121fa376558f.pdf",
            "news_date": "2023-08-04 13:38:34",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 5th May, 2023.",
            "news_id": "842a5b9f-bf35-4ed7-adb9-b38778240228",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b765bfe-2685-4055-9795-d33d278ed20b.pdf",
            "news_date": "2023-05-12 18:34:38",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/",
            "news_id": "486f4279-1808-48cf-abf8-efc6b20fd339",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bfb75a4-542f-4801-a85b-8cf9d625f897.pdf",
            "news_date": "2023-05-06 11:32:58",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation on the Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2023.We request you to kindly take the same on record.",
            "news_id": "2c6022d1-edc8-43fb-af91-921920b70e6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f746eb52-e2f3-4fbf-94f8-d341cf1d1c6a.pdf",
            "news_date": "2023-05-05 17:11:10",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Financial Results",
            "news_body": "The exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia Approved the Audited Financial Results for the quarter and financial year ended''31st March, 2023. and Recommended a dividend of Rs. 8/- (400%) per Equity Share.",
            "news_id": "ae4bce51-becc-421d-a812-5851eb625a71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35de2f20-ebec-43a8-9983-e7f29274ba3f.pdf",
            "news_date": "2023-05-05 17:02:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 1st February, 2023.We request you to kindly take the same on record.",
            "news_id": "403ab9b6-3495-42b5-975b-ec2aca17aa92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ecfdf48-51b5-4b6d-aa3a-a22cec3f6356.pdf",
            "news_date": "2023-02-07 19:44:03",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/ We request you to kindly take the same on record.",
            "news_id": "654a2b01-1c19-4c1c-9c19-79ae641e891b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d881a07d-5cc0-4228-a515-eb6ad2702645.pdf",
            "news_date": "2023-02-01 20:19:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December, 2022",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the Unaudited Financial Results for the quarter and nine months period ended 31st December, 2022.",
            "news_id": "a5cc3ffc-1d41-4575-b1d3-04bbca648e9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0555b9f1-7be6-4611-a7d0-66640a3e8c56.pdf",
            "news_date": "2023-02-01 16:30:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the Unaudited Financial Results for the quarter and nine months period ended 31st December, 2022.",
            "news_id": "f81a7ff2-7e1b-4abb-941b-2e4909450216",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ace347c7-c5f1-482b-ad3e-582c9ebe2bc8.pdf",
            "news_date": "2023-02-01 16:27:05",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI Listing Regulations, 2015, we enclose herewith Disclosure of Related Party Transactions for the half year ended 30th September, 2022.We request you to kindly take the same on record.",
            "news_id": "3162909a-93b0-46f1-9752-fb3752d85bc9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=389b4945-6435-41e9-aa91-3f3840a27452.pdf",
            "news_date": "2022-11-24 19:21:34",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 11th November, 2022.We request you to kindly take the same on record.",
            "news_id": "b91092dc-f64f-4397-91ca-b511c22e6279",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f640dfc6-50c0-495a-8a8f-5550cf2ae0b7.pdf",
            "news_date": "2022-11-17 18:44:00",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/",
            "news_id": "24f9c227-b055-46fb-8658-9d79344bdb5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6e5ee77-f777-4f5c-bd10-9101f2070750.pdf",
            "news_date": "2022-11-11 20:40:28",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2022.",
            "news_id": "d108df89-04e4-44be-b180-ff092a0f285d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7a4b1f0-6fce-4149-9782-857a1bba2d6e.pdf",
            "news_date": "2022-11-11 13:46:50",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 4th August, 2022.We request you to kindly take the same on record.",
            "news_id": "6ae06a90-e759-4a6b-a76c-5d19eb1cbed2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb9d1d43-e4b3-42cb-90fc-36a4002667ac.pdf",
            "news_date": "2022-08-10 11:21:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2022.",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Unaudited Financial Results for the quarter ended 30th June, 2022.<BR> 2) Re-classification of the dividend of Rs. 10/- (500%) per equity share for the financial year 2021-22, recommended by them at their meeting held on 2nd May, 2022, into interim dividend for the financial year 2021-22. <BR> <BR> Please note that the said interim dividend will be paid to those shareholders whose names appear on the Register of Members as on the Record Date fixed for the purpose i.e. Thursday, 18th August, 2022. No further final dividend for the financial year 2021-22 shall be declared.<BR> <BR> The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 3:30 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "4776dbd1-a0da-4798-ba85-9934e3e40e53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3c9c1b4-3433-4074-a2f2-f18e90972d41.pdf",
            "news_date": "2022-08-04 17:36:01",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Unaudited Financial Results for the quarter ended 30th June, 2022.<BR> 2) Re-classification of the dividend of Rs. 10/- (500%) per equity share for the financial year 2021-22, recommended by them at their meeting held on 2nd May, 2022, into interim dividend for the financial year 2021-22. <BR> <BR> Please note that the said interim dividend will be paid to those shareholders whose names appear on the Register of Members as on the Record Date fixed for the purpose i.e. Thursday, 18th August, 2022. No further final dividend for the financial year 2021-22 shall be declared.<BR> <BR> The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 3:30 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "7bbc2936-28c8-4647-873e-d40a487e366e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2803057c-d821-4034-aff3-e9631934d052.pdf",
            "news_date": "2022-08-04 15:46:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015",
            "news_body": "With reference to the captioned matter, we would like to inform that pending the release of XBRL template in the new format prescribed by SEBI vide its Circular dated 22nd November, 2021 on Disclosure obligations of listed entities in relation to Related Party Transactions and based on the verbal guidance provided by the stock exchanges, we enclose herewith scanned copy of disclosures on Related Party Transactions for the half year ended 31st March, 2022. We will upload the said disclosures in XBRL as and when the template is released by the stock exchanges.We request you to kindly take the same on record.",
            "news_id": "d3af5ae7-0e35-40b6-9a69-40026b0b1b7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd7f1a95-12d1-4133-a4e1-ea312ad9b653.pdf",
            "news_date": "2022-05-16 19:54:01",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 2nd May, 2022.We request you to kindly take the same on record.",
            "news_id": "3c178b00-9934-49c8-9675-2622d9e25c98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56abeb04-b7f4-4450-a7a7-9f1b14c98826.pdf",
            "news_date": "2022-05-09 16:36:40",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/ We request you to kindly take the same on record.",
            "news_id": "0245bb5e-a5d2-43cf-ad86-072ac2f4231b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69c6dea9-d878-49a0-998e-18eb95930525.pdf",
            "news_date": "2022-05-03 13:44:43",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2022.",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Audited Financial Results for the quarter and financial year ended 31st March, 2022.<BR> <BR> 2) Recommended a dividend of Rs. 10/- (500%) per Equity Share having face value of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual General Meeting.<BR> <BR> The time of commencement of the Board Meeting was 2:00 p.m. and the time of conclusion was 3:35 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "7baf5de7-5a39-4774-babe-5908b9759bd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c02a743-ab1a-4024-995b-07e217dd9185.pdf",
            "news_date": "2022-05-02 16:09:33",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Audited Financial Results for the quarter and financial year ended 31st March, 2022.<BR> <BR> 2) Recommended a dividend of Rs. 10/- (500%) per Equity Share having face value of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual General Meeting.<BR> <BR> The time of commencement of the Board Meeting was 2:00 p.m. and the time of conclusion was 3:35 p.m.<BR> <BR> We request you to kindly take the same on record.",
            "news_id": "56316cae-f729-40d8-8203-9b3ef493958f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94eb5db6-9dd4-4c0e-8dc4-e1389a545057.pdf",
            "news_date": "2022-05-02 15:58:57",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 28th January, 2022 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 10th February, 2022.We request you to kindly take the same on record.",
            "news_id": "7a25ee62-4287-48b4-b168-96e6e1884841",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13378744-332d-4471-92b2-c65752f90d88.pdf",
            "news_date": "2022-02-16 19:21:47",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December, 2021.",
            "news_body": "Unaudited Financial Results for the quarter and nine months period ended 31st December, 2021.<BR> <BR> Please find enclosed herewith standalone and consolidated financial results of the Company for the quarter and nine months period ended 31st December, 2021, Press Release and Investor Presentation.",
            "news_id": "860b819d-8ef3-40d8-95cd-a3ac90795dd5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be13d151-46d6-47a8-a4f7-d9408becf46a.pdf",
            "news_date": "2022-02-10 14:19:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the:   <BR> <BR> 1. Unaudited Financial Results for the quarter and nine months period ended 31st December, 2021.<BR> 2. Appointment of Mr. Ashok Barat (DIN: 00492930) as an Independent Director of the Company w.e.f. 10th February, 2022. The detailed disclosures is being submitted vide a separate communication.<BR> <BR> Please find enclosed herewith standalone and consolidated financial results of the Company for the quarter and nine months period ended 31st December, 2021, Press Release and Investor Presentation.<BR> <BR> The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 2:00 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "ba11f7c3-7a39-4c07-84c5-0ec4cb9cbb26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d993dfb2-bb32-4355-a1e6-4697a8ff778e.pdf",
            "news_date": "2022-02-10 14:14:26",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 29th October, 2021 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 10th November, 2021.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "e73b9d58-2a62-4739-9ac9-c80020cea9cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7d95702-c637-438a-a766-15dacf17da92.pdf",
            "news_date": "2021-11-19 19:09:00",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> The time of commencement of the Board Meeting was 12:20 p.m. and the time of conclusion was 1:45 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "5e075f58-a47a-4f70-8d53-ae0677378e42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57b46bb6-6c54-4fa5-8e5d-2bc629ade888.pdf",
            "news_date": "2021-11-10 14:02:30",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> The time of commencement of the Board Meeting was 12:20 p.m. and the time of conclusion was 1:45 p.m.<BR> <BR> We request you to kindly take the same on record.",
            "news_id": "d10d8d65-3a00-444f-89bc-7e69b7325c23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46a4c44-0644-44d2-938d-bcc4692b370d.pdf",
            "news_date": "2021-11-10 13:57:24",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 15th July, 2021 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 26th July, 2021.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "28ce6c9e-070f-40ec-8e8d-fc81c369f25a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc1e1156-1b64-4222-ba63-4108c6b11512.pdf",
            "news_date": "2021-08-02 13:22:04",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2021",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> <BR> We enclose herewith the following: <BR> a)  Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> b) Standalone Unaudited Financial Results for the quarter ended 30th June, 2021. <BR> c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.<BR> d) Press Release.<BR> e) Investor Presentation.<BR> <BR> The time of commencement of the Board Meeting was 1:30 p.m. and the time of conclusion was 2:50 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "484084ee-a97b-4ac1-b72d-fe3b489c0c84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=842666cb-d535-445f-9bad-e6f00d5b8696.pdf",
            "news_date": "2021-07-26 15:08:40",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> <BR> We enclose herewith the following: <BR> a)  Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> b) Standalone Unaudited Financial Results for the quarter ended 30th June, 2021. <BR> c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.<BR> d) Press Release.<BR> e) Investor Presentation.<BR> <BR> The time of commencement of the Board Meeting was 1:30 p.m. and the time of conclusion was 2:50 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "ec451a49-4869-4d86-bc79-afdbba937322",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8953cd4-8b09-4c89-b114-822833bca8ae.pdf",
            "news_date": "2021-07-26 15:05:30",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2021",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, 2015, we enclose herewith Disclosure of Related Party Transactions, on a consolidated basis, for the half year ended 31st March, 2021.",
            "news_id": "953ae82a-3734-4ff9-b51b-3a9a68f6e7d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49aad200-55ae-4472-af68-f3d9e5ceb0f8.pdf",
            "news_date": "2021-05-25 12:11:18",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 27th April, 2021 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 4th May, 2021.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "06f22de9-8f7b-409b-b73d-9c8877f7434a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=868ae8c2-ab6c-48ee-b5e9-bb31402d2498.pdf",
            "news_date": "2021-05-13 18:29:35",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2021",
            "news_body": "Please refer attached file with the attachments",
            "news_id": "cc900f5e-35a2-4c26-9092-2fafe94ce124",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59a57476-b0f4-456d-a77e-168f701cc8de.pdf",
            "news_date": "2021-05-04 14:35:01",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Please find attached herewith covering letter along with the documents.",
            "news_id": "6ac97efb-ce51-4524-98d9-74dffcb154e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e7eaab6-dd0d-4b9f-a9e3-28dccb1abae2.pdf",
            "news_date": "2021-05-04 14:25:08",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}